---
document_datetime: 2023-09-21 22:19:53
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/orkambi-epar-all-authorised-presentations_en.pdf
document_name: orkambi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9719518
conversion_datetime: 2025-12-21 11:16:52.171111
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength        | Pharmaceutical Form   | Route of Administration   | Immediate Packaging        | Pack size                        |
|------------------|-------------------|-----------------|-----------------------|---------------------------|----------------------------|----------------------------------|
| EU/1/15/1059/001 | Orkambi           | 200 mg / 125 mg | Film-coated tablet    | Oral use                  | blister (Aclar/PVC/alu)    | 112 (4 x 28) tablets (multipack) |
| EU/1/15/1059/005 | Orkambi           | 100 mg / 125 mg | Film-coated tablet    | Oral use                  | blister (Aclar/PVC/alu)    | 112 tablets                      |
| EU/1/15/1059/006 | Orkambi           | 100 mg / 125 mg | Granules              | Oral use                  | sachet (BOPET/ PE/Foil/PE) | 56 sachets                       |
| EU/1/15/1059/007 | Orkambi           | 150 mg / 188 mg | Granules              | Oral use                  | sachet (BOPET/ PE/Foil/PE) | 56 sachets                       |
| EU/1/15/1059/008 | Orkambi           | 75 mg / 94 mg   | Granules              | Oral use                  | sachet (BOPET/ PE/Foil/PE) | 56 sachets                       |